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Abstract
Aim of the work. Determine the effectiveness of prenatal diagnosis of congenital heart defects in the fetus and the informa-
tiveness of different markers used in the medical-genetic counseling of pregnant women.. 
Materials and methods. The analysis of the results of medical genetic counseling of pregnant women with fetal heart diseas-
es was carried out. The effectiveness of using different methods of prenatal diagnosis in 67 pregnant women is estimated. The data 
of somatic, genealogical and reproductive anamnesis, biochemical markers of chromosomal pathology of the 1st and 2nd trimester 
of pregnancy, and the spectrum of the detected fetal heart disease were studied.
Results of the research. It was found that 46 (68.7 %) women had somatic diseases: pathology of the cardiovascular sys-
tem (11.9 %); endocrine system - at 8 (11,9 %); respiratory disease – 3 (4.5 %) and urinary system – 2 (3.0 %). 13 (19.4 %) out of 
67 women had acute respiratory viral infections in the first trimester of pregnancy. In 4 (6 %) cases – bad habits. The first time 
pregnant were 31 (46.3 %) women, 21 (31.3 %) – the second time, 10 (14.9 %) in the third, and 5 (7.5 %) in the fourth or more 
times. In history, 58 (86.6 %) women did not have reproductive function disorders, 8 (11.9 %) had unauthorized miscarriages 
and frozen pregnancy. The burden of gynecological anamnesis was observed in 12 (17.9 %) women, and hereditary – in 6 (9.0 %) 
women. In the structure of congenital defects of the heart, false anatomical anomalies were found more often: hypoplasia of 
the left heart organs – 14 (20.9 %), tetralogy of Fallot – 9 (13.3 %). Biochemical markers of chromosomal pathology in the first 
trimester in 11 (16.4 %) women recorded indicators that are characteristic of the risk of chromosomal pathology, and in the 
second trimester – in 9 (13.4 %). Two pregnant women used a NIPT (non-invasive prenatal test) test that did not detect chro-
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mosomal abnormalities in the fetus. In 8 cases, invasive prenatal diagnosis of the fetus was recommended, which was carried 
out by three women, and five refused.
Conclusions. The peculiarities of somatic (in 46–68.7 % of women), reproductive (in 8–11.9 % of women) gynecological 
anamnesis (in 12–17.9 % of women), which can be the risk factors of congenital fetal heart disease, are revealed. In the structure of 
congenital defects of the heart of the fetus more often revealed hypoplasia of the left heart organs – 14 (20.9 %), tetralogy of Fallot – 
9 (13.3 %). In 11 (16.4 %) women recorded indicators of biochemical markers, characteristic for the risk of chromosomal pathology, in 
the first trimester, and – in 9 (13.4 %) pregnant women – in the second trimester. Comparative data on prenatal diagnosis of congen-
ital heart defects in the fetus of chromosomal, monogenic and multifactorial etiology are given. On the basis of the obtained results 
an algorithm of medical-genetic counseling of this contingent of patients was offered.
Keywords: prenatal diagnosis, medical genetic counseling, congenital heart defects.
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1. Introduction
The incidence of congenital heart defect (CHD) in the world ranges from 10 to 13 cases 
per 1,000 children born alive [1, 2]. In Ukraine, the average CHD frequency ranges from 8–9 to 
11–13 cases per 1,000 live births [3, 4]. CHD make up the majority of congenital fetal pathology. 
The basis for early detection of any congenital malformations is well organized screening of preg-
nant women. In many countries, fetal echocardiography is a routine method of study for all preg-
nant women [5, 6]. However, the experience of foreign colleagues shows that even with complex 
cardiac anomalies (such as full form atrioventricular channel or hypoplasy of left part of the heart), 
suspected heart defect occurs only in half of cases [7]. Medium CHD detection rate in the prena-
tal period in Western Europe is 19–49 %, in Eastern – 8 % [8, 9]. There is no exact data on these 
indicators in Ukraine. There is insufficient data on the algorithms of medical genetic counseling, 
since a significant part in the etiology of CHD is chromosomal or monogenic etiology. In Ukraine, 
moreover, there is the lack of high-tech equipment and qualified doctors in fetal cardiology; they re-
quire constant improvement and there is insufficient coverage of pregnant women with ultrasound 
screening [10, 11]. 
Reduce the incidence of congenital malformations can be achieved by individual prevention 
of congenital heart disease (prevention of preconception and prenatal diagnostics), CHD moni-
toring frequency and definition of negative risk factors incurred. Prenatal diagnosis reveals about 
49 % of heart disease in the fetus, and helps to optimize the results of surgical correction of com-
plex CHD in newborns and infants [12, 13].
Methods of prenatal diagnosis are divided into indirect when the object is a pregnant 
woman, and straight when doctor study fetus. It should be noted that the main purpose of indirect 
methods – selection of women at high risk for further in-depth observation and medical genetic 
counseling. 
Medical genetic counseling (MGC) is an important part of every stage of the system of 
preventive measures, a prerequisite for the effective functioning of which is cooperation among 
specialists in genetic monitoring system.
At present, the only way to reduce congenital and hereditary diseases is preventive mea-
sures, which are distributed in stages: 
a) prevention preconception that includes, besides readjustment family when planning preg-
nancy, measures to reduce exposure to controlled environmental factors; 
b) prenatal diagnosis of congenital and hereditary diseases of the fetus, which provides de-
tection of fetuses with congenital disorders and hereditary disease, followed by surgical correction; 
c) screening massive and selective programs among newborns that can detect certain patho-
logical conditions and provide adequate medical care to sick children; 
d) early surgical correction of birth defects [14, 15]. 
Non-invasive methods for prenatal diagnosis are used widely and include: triple ultrasound 
evaluation of the mandatory ultrasound markers of chromosomal aberrations (collar area, the size 
of the nasal bone, Doppler venous duct in the first trimester, the thickness of the neck fold ratio of 
femur length biparietal to size, etc.) and determination of serum biochemical markers of pregnant 
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(PAPP - protein (associated with pregnancy plasma protein-A), βhCG (B-subunit of human chori-
onic gonadotropin) in the first trimester and aFP (alfa-fetoprotein) hCG, unconjugated estriol - in 
the second trimester).
It is believed that the result of prenatal ultrasound is affected mainly with technical reasons 
(resolution device, the pregnancy, the thickness of the anterior abdominal wall of the mother, the 
position and size of the fetus, the drug experience). However, a significant role to play also features 
the formation and various hemodynamic CHD. Despite the fact that the anatomical details of the 
fetal heart can be seen from 12-14 weeks, various manifestations can vary significantly CHD that 
determines the timing of diagnosis [16, 17]. 
Researchers in majority of countries have concluded that identify the structure of the 
heart can have 14 weeks of pregnancy [18]. However, the optimal gestational time to study the 
cardiovascular system of the fetus after 20–22 weeks of pregnancy. During this period, complex 
structural abnormalities of the heart reveal, such as ventricular hypoplasia or large artery wall 
hypertrophy ventricular atrial enlargement [14, 18]. In addition, according to many authors, early 
studies of the heart of the fetus at 14 weeks does not always give an adequate picture of cardio-
vascular disease, as the growth of cardiac structures takes place for the duration of pregnancy 
(from aortic stenosis until critical stenosis of the aorta, leading to atresia and ends hypoplastic 
syndrome) [18].
Given that the prognosis, treatment approaches, and CHD primary prevention of fetal mal-
formations affect etiology, chromosomal, monogenic or multifactorial origins, an important issue 
is the MGC detection algorithm of heart defects in the fetus. Conflicting data are available on the 
relationship of frequency and structure of prenatally detected CHD with chromosomal disorders 
[19, 20]. Need to optimize diagnostic methods for determining the etiology of heart disease is al-
ready present in the prenatal period. Therefore, the relevant issue is the elaboration of approaches 
to medical genetic counseling this group of women, and to develop recommendations for the pre-
vention of CHD in the fetus. 
Against the background of reduced fertility and increased mortality in Ukraine, including 
a child, growing morbidity and disability of children associated with CHD (40–50 % of perinatal 
mortality and morbidity by 30 %) [21, 22], acquires relevance the need for effective prevention of 
CHD, timely and adequate prenatal testing and development (improvement) algorithms of MGC 
unified with CHD fetus.
2. Aim of the research
Determine the effectiveness of prenatal diagnosis, information of various markers of con-
genital heart defects in the fetus and to propose an algorithm of medical genetic counseling of this 
pregnant women population.
3. Materials and methods
We analyzed data cards of pregnant women, who gave birth to children with CHD for pe-
riod of 5 years (2011–2015) in the Lviv regional clinical hospital and medical genetic counseling 
results of 67 pregnant women aged 18–42 years (average age amounted to 26.8±6.6) diagnosed 
with fetal heart defects that are addressed in Medical Genetics center SI “Institute of genetic 
pathology Medical Sciences of Ukraine (MGC), in Lviv on suspicion of fetal CHD for the pe-
riod 2011–2015 and changes in biochemical screening markers during pregnancy. The criterion 
for inclusion in the group was having a baby with a clinical diagnosis “Congenital heart defect” 
according to ICD-10 (Q20–Q28 Congenital malformations of the circulatory system) and the 
availability of medical genetic conclusion during pregnancy. During the work, we evaluated 
the effectiveness of different methods of prenatal diagnosis in 67 pregnant women with CHD 
fetus, which had ultrasound fetal diagnosis of CHD that was made prenatally, studied data of 
physical, family and reproductive history, biochemical markers and second trimester of preg-
nancy, and spectrum of the detected heart disease in the fetus. Statistical analysis of the results 
was performed by the method of variation statistics using computer programs “Statistica 6.0” 
and “Excel 5.0”. 
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4. Results of the research 
The program of medical and genetic counseling of pregnant women with diagnosed fetal 
heart defects found prenatally, studied somatic, reproductive history and genealogy. It was found 
that 21 (31.3±0.04 %) women had a physical illness, such as pathology of the cardiovascular sys-
tem – 8 (11.9±0.04 %), of which 1 (1.5±0.01 %) woman had mitral valve prolapse, 5 (7.5±0.06 %) – 
varicose veins of the lower extremities, 2 (3.0±0.02 %) – hypertension; endocrine system – 
8 (11.9±0.04 %), of which 2 (3.0±0.02 %) women had obesity, 1 (1.5±0.01 %) – diabetes type 1, 
and 5 (7,5±0,04 %) - hyperplasia of the thyroid gland. The number of women diagnosed with the 
respiratory disease (chronic bronchitis) and urinary tract (chronic pyelonephritis) – 3 (4.5±0.03 %) 
and 2 (3.0±0.02 %). 
It was found that 13 of 67 women (19.4±0.03 %) suffered acute respiratory viral infection in 
the first-second trimester and 1 (1.5±0.01 %) woman suffered measles. In 4 (6.0±0.03 %) pregnant 
we marked bad habits: 3 – (4.5±0.02 %) – smoking, 1 (1.5±0.01 % %) – had professional activities 
connected with varnishes and paints. 
Almost half of the women were pregnant for the first time – 31 (46.3±0.04 %), 21 (31.3± 
±0.04 %) – in the second time, 10 (14.9±0.02 %) in the third and 5 (7.5±0.04 %) in four or more times. 
Most women – 58 (86.6±0.04 %) reproductive patient had no history. Only 8 (11.9±0.04 %) 
patients were observed before this pregnancy and spontaneous abortions sank pregnancy, and pre-
vious pregnancy of one woman was complicated by fetal congenital disorders (hydrocephalus and 
cerebrospinal hernia). 
Violation of gynecologic history was observed in 12 (17.9±0.01 %) of this group of pregnant 
women 10 (14.9±0.02 %) before pregnancy had chronic inflammatory gynecological diseases, 2 
(3.0±0.02 %) – ovarian cysts. In one woman (1.5±0.01 %) the pregnancy was the result of IVF (in 
vitro fertilization).
In the study of family history of CHD female fetus we found that heredity was burdened 
in 6 (9.0±0.05 %) women, 2 (3.0±0.02 %) women had congenital anomalies of the urinary system, 
1 (1.5±0.01 %) case of congenital deafness, congenital cataracts, hereditary hypertension, cerebral 
palsy unknown etiology. 
All 67 women experimental group were registered in antenatal clinics in the place of the 
residence. 
Study of the CHD structure, who were diagnosed prenatally according to the conclusions 
of Medical Genetic Center obtained from the analysis of medical records route from studying the 
history of newborns with CHD, cards pregnant found that often are identified gross anatomical 
anomalies such as hypoplasy of left part of the heart – 14 (20.9±0.01 %), tetralogy of Fallot – 
9 (13.3±0.03 %) and large defects, ventricular septal defect (VSD) + atrial septal defect (ASD) + 
open oval window (OOW) + patent ductus arteriosus (PDA) – 9 (13.3±0.03 %). 
The analysis of the diagnostic date for CHD in the fetus showed that only one pa-
tient (1.5±0.04 %) CHD (tetralogy of Fallot) was detected in the first trimester of pregnancy, in 
24 (35.8±0.02 %) women – in ІІ trimester and, unfortunately, in most cases – 42 (62.7±0.02 %), this 
pathology was diagnosed in the third trimester of pregnancy. The latter limited the diagnostic capa-
bilities of specialists, the timely conduct of a prenatal consultation to determine the tactics, method 
and place of delivery, as well as the psychological preparation of a pregnant woman.
Considering that, the prognosis of the course approaches to treatment, and the main further 
prevention and prediction of CHD in the fetus affects the etiology of the defect: chromosomal, 
monogenic or multifactorial genesis, analyzed the differences that affect the tactics of MGC for 
this contingent of patients.
Diagnostic methods that we recommend to include in the algorithm of medical-genetic 
counseling of CHD, depending on the etiology, are shown in Table 1.
Conflicting is the data on the association of the frequency and structure of prenatal CHD 
detected with chromosomal pathology [19, 20]. Diagnostic methods for determining the etiolo-
gy of heart defects already in the prenatal period are required to optimize. Therefore, the urgent 
question is the elaboration of approaches to the medical-genetic counseling of such a contingent 
of women, as well as the development of recommendations for the prevention of CHD in the fetus. 
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To exclude the risk of chromosomal diseases in the fetus, a comprehensive study was conducted on 
the levels of biochemical markers in the 1st and 2nd trimesters of pregnancy. In the first trimester, 
serum pregnancy levels determined the level of protein A associated with pregnancy (РАРР-А) and 
the free subunit of chorionic gonadotrophin (βhCG). 
Table 1
Diagnostic methods for determination of etiology of CHD with medical genetic advising
Indexes
Etiology of CHD
Chromosomal anomalies Monogene defects Multifactorial  (including teratology)
Examples 
– Down Syndrome 
– Edwards 
– Patau 
– Terner
– VACTERL-association 
– Di Joggi 
Williams 
– Nunan syndrome 
– Kabuki syndrome 
– Holt-Oram Sidrome
– Isolated defect 
– MGM
Postnatal percentage [%] 20 % 10 % 70 %
Review of fetus heart in I 
trimester
Pathological flow in the venous 
duct, tricuspid edentural regur-
gitation in 90 %
Pathological flow in the venous 
duct, tricuspid regurgitation
Pathological flow in the venous 
duct, tricuspid regurgitation in 
part of cases
Other biochemical and ultra-
sound markers
Thickening of collar space, 
hypoplasia of the nasal bone  
РАРР-А ↓ + bhCG ↑  
aFP ↓ + bhCG+f-Е3 ↓
in 90 %
Thickening of collar space – 
1–2 % 
Biochemical markers are 
normal
Normal
Risk for the following preg-
nancies
5–17 % (depends on the type 
of chromosomal pathology, the 
presence of structural changes 
in parents)
25 % 2–9 %
Features of MGC and pre-con-
ceptual prevention
Cariotype of spouses, folic 
acid 5 mg/day, expert ultra-
sound in I trimester, in the 
presence of structural changes 
in the karyotype – IPD (am-
niocentesis + fetal karyotype)
Molecular genetic analysis, 
DNA sequencing, microarray, 
folic acid 5 mg/day, expert 
ultrasound and trimester, IPD 
(сhorionic villus sampling) + 
molecular genetic analysis
Folic acid 5 mg, avoidance of 
harmful factors of the environ-
ment, expert ultrasound in the 
first trimester
The proportion of prenatally 
found in this study
Five women were suspected, 
but 5 women refused to  
receive IDP
(92 %)*
Note: * These cases need to be verified in the postnatal period; IPD – invasive prenatal diagnosis; MGM – multiple congenital 
malformations
The highest percentage of women with fetal CHD had an elevated РАРР-А level and a low-
ered bhCG level of 77.6±0.01 %; with a low level (less than 0.5 MoM) of РАРР-А and a low level of 
hCG was 16.4±0.01 %, low RARR-A and elevated hCG-6.0±0.01 %. Pregnant women who found 
a lowering of PARR-A in the blood have expanded the complex of prenatal measures in the sec-
ond trimester using invasive methods. Pregnant women who showed increased RARR-A in blood 
with a parallel underestimation, a study of levels of biochemical markers in the second trimester 
(16–18 weeks) – aFP, hCG, f-E3. Thus, in 16.4±0.01 % of women, the biochemical markers of the 
I trimester indicated a risk from the fetus’s chromosomal pathology, and such pregnant women 
needed further in-depth methods for prenatal diagnosis, which was confirmed by the biochemical 
markers of the II trimesters at 13.4±0.03 % of women.
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Thus, a decrease in aFP with an increase in bhCG was observed in 13.4±0.03 % of women 
with fetal CHD, an increase in aFP and an understatement of n-E3 in 76.1±0.01 %. An elevated 
level of aFP (greater than 2.5 MoM) with a parallel undershot of HG and n-E3 was observed at 
10.5±0.06 %. Pregnant women with a reduced aFP level and elevated hCG levels were subsequently 
recommended for invasive prenatal diagnostic (IPD).
To exclude chromosomal pathology, 8 women were recommended for an IPD, which was per-
formed by three women. Two pregnant women conducted a NIPT test - an analysis of a fetal karyo-
type of maternal blood that did not detect chromosomal abnormalities. Five pregnant women refused 
to conduct an invasive PD. Of the 67 women, 9 were counseled at the National Institute of Cardio-
vascular Surgery named after M. M. Amosov or in the “Scientific and Practical Medical Center for 
Pediatric Cardiology and Cardiology” of the Ministry of Health of Ukraine for the development of the 
tactics of delivery and postnatal correction of congenital heart defect of a newborn child.
On the basis of the obtained results, an algorithm of medical-genetic counseling of women 
with CHD in the fetus is proposed in the prenatal, postnatal and subsequent pre-conceptional stag-
es (Fig. 1).
Fig. 1. Algorithm of medical-genetic counseling of women with fetal CHD
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5. Discussion of the results
The data obtained by us show that in the structure of the CHD of the fetus more often 
revealed rude anatomical anomalies, such as hypoplasia of the left heart organs – 14 (20.9 %), te-
tralogy of Fallot – 9 (13.3 %), and major defects of VSD + VSD + PDA – 9 (13.3 %). However, they 
were diagnosed with the majority in the third trimester of pregnancy (62.7 %). The determining 
factors influencing the accuracy of prenatal diagnosis of CHD are professional qualifications and 
the quality of visualization. Several researchers are convinced that today all heart defects can be 
diagnosed, even in the first trimester of pregnancy, but the result of the diagnosis depends on the 
quality of the ultrasound equipment, professionalism of the specialist [14, 15]. The two-level system 
of prenatal diagnostics allows to determine with high degree of reliability the congenital malfor-
mations of the heart. At the same time, the system does not work efficiently: at present, more than 
60 % of birth defects in the heart have been diagnosed only in the third trimester. Since we ana-
lyzed the data for 2011-2015, one can hope that at present the level of diagnostics, taking into ac-
count the qualifications of specialists and equipment upgrades, is somewhat higher.
To find out the likely factors of increased risk of CHD in the fetus during the medical genetic 
counseling, data of the features of the somatic, reproductive gynecological history of women who 
have been diagnosed with fetal CHD during pregnancy were collected and analyzed. Thus, 31.3 % 
of females with fetal CHD had somatic diseases, the most frequent were cardiovascular (11.9 %) 
and endocrine (11.9 %). 11.9 % of women had a history of involuntary miscarriage, frozen pregnan-
cy, congenital disorders of the fetus. 17.9 % of women in this group have gynecological disorders: 
chronic inflammatory diseases, ovarian cysts. These factors may be a potential risk factor for con-
genital fetal heart disease. However, for the formulation of evidentiary findings, further analysis 
and comparison of the obtained indicators with the data of the control sample – a group of women 
who gave birth to healthy children. We assume that individual values   regarding the history of 
women with CHD in the fetus will coincide with the control sample. Complications from somatic, 
genetic, reproductive history in women may be a risk factor for CHD. Such confirmation was found 
in the data of Lastivka I. V. et al. [20].
Detection of chromosomal pathology during pregnancy is an important task for prenatal 
diagnosis. Use of biochemical markers of congenital and chromosomal pathologies of the I and II 
trimesters in women with congenital heart defects, although it allowed to suspect chromosomal 
pathology, but unfortunately, did not serve as a sign of CHD in the fetus. Since, for the differ-
entiation of the etiology of CHD, biochemical and ultrasound scoring markers are important for 
the markers of chromosomal pathology in the fetus, a retrospective analysis of these indices was 
performed in women with fetal CHD. The biochemical markers of chromosomal pathology, which 
are defined in the first trimester of pregnancy, were changed in 16.4 % and in the second trimester 
in 13.4 % of women with congenital heart defects. These women were offered further research to 
exclude chromosomal abnormalities. In order to exclude chromosomal pathology, women were rec-
ommended for an invasive PD, which had been approved by less than half of women, which could 
be explained by low awareness of this procedure and doubts about possible negative consequences. 
Many advantages in such cases are the implementation of non-invasive prenatal diagnosis (NIPT) – 
an analysis of the fetal karyotype of the mother’s blood. Negative limitation of this analysis is its 
high cost. Among the women surveyed, this study was conducted in two cases and did not reveal 
chromosomal abnormalities. Such results allow us to form a positive outlook for the pathology of 
the fetus, but do not exclude a monogenic defect. We consider compulsory review of genetics after 
the birth of a child with CHD in order to identify a possible symptom that will indicate monogenous 
nosology and will require special studies
Five pregnant women refused to conduct an invasive PD. This work also reveals many 
ethical issues that need to be addressed. The duty of the geneticist is to report to the patients all 
options for the disease with all possible consequences and to support families in implementing 
their decision.
An optimized algorithm for medical genetic counseling, presented in Fig. 1, was proposed 
to improve the system of pre-conceptional prevention and early diagnosis of CHD, effective medi-
co-genetic counseling and prediction of healthy offspring.
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Another important issue is the detection of critical forms of CHD, which will allow in the 
future to provide cardiologic and cardiac surgery to the child in a timely manner after birth and 
to avoid tactical mistakes in conducting patients in the neonatal period. About 50 % of cardiac 
anomalies account for complicated heart defects, in which provision of specialized medical care is 
necessary in the first days, months, and sometimes in the first hours of the child’s life. According 
to Boguta L. Yu. et all, among children born with heart anomalies, 14 % die in the first week of 
life, 25 % – during the first month, about 40 % – do not survive during the first year [21]. In ad-
dition, most complex CHDs are associated with chromosomal abnormalities, genetic syndromes 
or multiple developmental abnormalities [14]. This circumstance dictates the need for the earliest 
possible prenatal detection of this category of CHD, which will make it possible to decide on the 
most appropriate tactics for the further conduct of pregnancy and the organization of childbirth in 
specialized maternity hospitals, will provide timely surgical correction of CHD in cardiac surgery 
clinics. Therefore, some patients in the study group were referred to specialized cardiac surgeries 
in Ukraine for further assistance. 
6. Conclusions
1. While medical genetic counseling we found some peculiarities of physical, reproductive 
gynecological history, which may be the likely risk factors for congenital heart disease of the fetus. 
Among women with suspected fetal CHD were recorded in 31.3 % of somatic diseases, most of 
which were cardiovascular pathology (11.9 %) and endocrine systems (11.9 %). In 11.9 % of women 
had a history of spontaneous abortion, missed abortion, congenital disorders of fetus. 17.9 % of 
women in this group had gynecological disorders: chronic inflammatory disease, ovarian cysts.
2. The structure of congenital heart defects that are diagnosed in the prenatal period, dom-
inated by gross anatomical abnormalities, hypoplastic left part of the heart (20.9 %), tetralogy of 
Fallot (13.3 %) and interventricular defects of atrial walls (13.3 %).
3. In most cases, prenatally detected CHD was diagnosed in the third trimester of preg-
nancy – 62.7 %, in the second trimester – 35.8 %, in the first trimester – 1.5 %. Late diagnosis of 
CHD limited the possibilities of specialized professionals timely prenatal consultation to determine 
the tactics, method and place of delivery, as well as psychological preparation of pregnant women.
4. During the determination of biochemical markers of chromosomal abnormalities in 
the first trimester, 16.4 % of women with congenital heart disease of the fetus had indicators of 
risk characteristic chromosomal aberrations and in second trimester that was observed in 13.4 % 
of women. Because of MGC, 8 women suspected chromosomal etiology of CHD, verified were 
only 5, but unfortunately postnatal through rejection of IPA.
5. Based on the results of the algorithm, medical genetic counseling of women with fetal 
CHD in prenatal, postnatal and further preconception periods.
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